• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

BOSTON SCIENTIFIC CORPORATION SYNERGY; CORONARY DRUG-ELUTING STENT Back to Search Results
Model Number 10618
Device Problem Adverse Event Without Identified Device or Use Problem (2993)
Patient Problems Atrial Fibrillation (1729); Death (1802)
Event Date 05/20/2019
Event Type  Death  
Manufacturer Narrative
Device is a combination product.
 
Event Description
It was reported that the patient died.The patient presented with poor left ventricular (lv) function and needs to undergo percutaneous coronary intervention (pci).The physician decided to do the pci with intra-aortic balloon pump (iabp).The target lesion was located in a coronary artery.The lesion was treated with stent implantation using 2.50x48mm and 3.0x16mm synergy drug-eluting stents and the procedure was completed.Post procedure, the patient felt better.Since the patient's lv function still not good enough, the iabp was kept in his body and was observed.Four days later, the patient died due to atrial fibrillation and no time to rescue.
 
Event Description
It was reported that the patient died.The patient presented with poor left ventricular (lv) function and needs to undergo percutaneous coronary intervention (pci).The physician decided to do the pci with intra-aortic balloon pump (iabp).The target lesion was located in a coronary artery.The lesion was treated with stent implantation using 2.50x48mm and 3.0x16mm synergy drug-eluting stents and the procedure was completed.Post procedure, the patient felt better.Since the patient's lv function still not good enough, the iabp was kept in his body and was observed.Four days later, the patient died due to atrial fibrillation and no time to rescue.It was further reported that the 2 synergy stents did not contribute to the patient's death because the patient has a very poor lv function and it was confirmed that patient died due to heart failure.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
SYNERGY
Type of Device
CORONARY DRUG-ELUTING STENT
Manufacturer (Section D)
BOSTON SCIENTIFIC CORPORATION
two scimed place
maple grove MN 55311
Manufacturer (Section G)
BOSTON SCIENTIFIC IRELAND LIMITED
ballybrit business park
galway
EI  
Manufacturer Contact
jay johnson
two scimed place
maple grove, MN 55311
7634942574
MDR Report Key8691561
MDR Text Key147738701
Report Number2134265-2019-05680
Device Sequence Number1
Product Code NIQ
Combination Product (y/n)N
Reporter Country CodeTW
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,foreig
Reporter Occupation Physician
Type of Report Initial,Followup
Report Date 08/07/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received06/12/2019
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date04/21/2020
Device Model Number10618
Device Catalogue Number10618
Device Lot Number0022878608
Was Device Available for Evaluation? No
Is the Reporter a Health Professional? Yes
Date Manufacturer Received07/17/2019
Was Device Evaluated by Manufacturer? Device Not Returned to Manufacturer
Date Device Manufactured10/24/2018
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
Patient Outcome(s) Death;
Patient Age72 YR
-
-